In this issue:
Latent treatment to reduce progression to multidrug-resistant TB
Vancomycin vs metronidazole for CDI
Recombinant influenza vaccine efficacy in adults ≥50 years
Itraconazole vs amphotericin B for HIV-associated talaromycosis
Trimethoprim-sulfamethoxazole vs ciprofloxacin for pyelonephritis
Timing of surgical antimicrobial prophylaxis
Drug-resistant tuberculous meningitis
Novel long-acting antimalarial DSM265
DSM265 for Plasmodium falciparum chemoprophylaxis
Cefazolin vs nafcillin or oxacillin for treatment of MSSA
Please login below to download this issue (PDF)